Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Merck KGaA acquires JSR chromatography business

 April 2, 2026

Pharmaceutical Technology

Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.

M&A / DealsRead full story

Post navigation

Alzheimer’s biotech Korsana to go public via reverse merger →
← Threat of Trump’s pharma tariffs looms again

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com